|
|
|
|
Tata Memorial Centre, Mumbai is on the cusp
of a momentous year, namely, the 75th year of its existence.
This platinum jubilee conference will be devoted to challenging the current
dogmas and to debate the ‘currently entrenched versus contrarian viewpoints’ in cancer research and treatment. It is likely to be a landmark conference, the first of its kind – not to be missed! Read More
|
RA Badwe
Chairman & Director, TMC
|
Indraneel Mittra
Chair, Scientific Committee
|
Rakesh Jalali
Organising Secretary
|
Amit Dutt
PI, Actrec & Advisor
|
|
|
|
|
Venue: National Centre for
the Performing Arts
|
|
|
|
|
|
- Has targeted therapy fulfilled its promise?
- Is precision medicine an achievable goal?
- Cancer research in need of a scientific revolution
- Cancer as an infectious disease caused by dead-cell chromatin
- How relevant are the randomized controlled trials in clinical practice?
- Harms of cancer screening
- Harnessing technology for cancer treatment; who benefits?
- Therapeutic strategies to harness the peri-operative window
- Has the molecular revolution reached the bedside?
- New insights in cancer metastasis, tumourheterogeneity and therapy resistance
- The promise of cancer immunotherapy
- The lure and promise of technology
- Omics and big data sets: Does statistical significance equal clinical relevance?
- Biological principles and clinical results of metronomic therapy
- GWAS: Are risk variants biologically and clinically relevant?
- Thinking Outside the Box in Cancer Research: Perspectives from the US NCI – Douglas Lowy
- Future of Oncology: European perspective –
Alberto Costa
- Fractal geometry in oncogenesis – Michael Baum
- Prometheus bound – stalling innovation in successful societies – Jan Vijg
 
|
|
Nicolas Andre
Marseille, France
|
Douglas Lowy
Director, NCI
Bethesda, USA
|
|
Rajendra Badwe
Mumbai, India
|
Indraneel Mittra
Mumbai, India
|
|
Michael Baum
London, UK
|
Lorelei Mucci
Boston, USA
|
|
Christopher Booth
Ontario, Canada
|
Amit Oza
Toronto, Canada
|
|
Michael Brada
Liverpool, UK
|
Julian Peto
London, UK
|
|
David Collingridge
Editor-in-chief,
The Lancet Oncology
|
Vinay Prasad
Washington, USA
|
|
Alberto Costa
Director, European School
of Oncology, Milan, Italy
|
Michael Retsky
Boston, USA
|
|
Ronald A Depinho
President, MDACC
Houston, USA
|
Hope S. Rugo
San Francisco, USA
|
|
Tito Fojo
New York, USA
|
Carlos Sonnenschein
Boston, USA
|
|
Gordon Freeman
Boston, USA
|
Ana Soto
Boston, USA
|
|
Varsha Gandhi
Houston, USA
|
Nikolas Stoecklein
D=C3=BCsseldorf, Germany
|
|
Mary Gospodarowicz
Toronto, Canada
|
Richard Sullivan
London, UK
|
|
Daniel Hayes
Michigan, USA
|
Ian Tannock
Toronto, Canada
|
|
David Jaffray
Toronto, Canada
|
Christophe Le Tourneau
Paris, France
|
|
Vijay K. Kuchroo
Boston, USA
|
Edward L. Trimble
NCI, USA
|
|
Jan Vijg
New York, USA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
